Oncology is simultaneously one of healthcare's greatest success stories and one of its biggest financial challenges. Cancer care continues to benefit from breakthroughs in precision medicine and early detection, even as oncology spending is projected to approach $200 billion by 2029. At the same time, cancer programs are facing rising patient volumes, growing demand for advanced therapies, and mounting pressure to improve access and affordability.

In this episode, hosts Abby Burns and Chloe Bakst welcome oncology expert Gaby Marmolejos to break down the trends shaping cancer care in 2026 and beyond. Together, they explore improvements in community-based access to advanced therapies, the promise of multi-cancer early detection testing, and the reimbursement challenges threatening program sustainability.

We’re here to help:

Playbook | Cell and gene therapy programs: How to launch, optimize, and deliver CGTs sustainably
Roundtable referenced | Advisory Board Oncology Roundtable: Trends and tech you can’t ignore
Webinar | The top 4 trends in oncology today
Report | Prioritizing equity in cancer treatment: Emerging ideas
Episode | 270: Service line snapshot: What every health leader needs to know
Episode | Ep. 209: Predicting what oncology will look like in 2030

Help shape Advisory Board’s next research agenda by taking our quick survey — share your priorities and challenges to ensure our research reflects what matters most to healthcare leaders like you.

A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.